News

IMP and Birnstiel Foundation honour three young scientists with research award

Emily Bayer of Columbia University, Mohamed El-Brolosy of the Max Planck Institute for Heart and Lung Research, and Justin Silpe of Princeton…

Read more

Campus Open Day: 11 October 2019

Visit the Vienna BioCenter on Friday, 11 October 2019 and learn about research opportunities at our campus.

Read more

ERC Starting Grant for IMBA Group Leader Alejandro Burga

Alejandro Burga, group leader at IMBA - Institute of Molecular Biotechnology, has been awarded the Starting Grant of the European Research Council,…

Read more

ERC funds to help predict drug responses

An ERC Proof of Concept Grant has been awarded to IMP Group Leader Johannes Zuber. He will use the funds towards the development of a diagnostic…

Read more

ERC grant for incoming IMP scientist Francisco Balzarotti

Francisco Balzarotti will join the IMP as Group Leader in January 2020. He will use funds from a recently awarded ERC Starting Grant to develop a…

Read more

CDK8 & CDK19 – Twin enzymes with non-twin roles in defense against viruses

The enzyme CDK8 and its paralog CDK19 are essential modules of the Mediator, a large protein complex that coordinates several key steps in…

Read more

Why are small RNA so important?

Sebastian Falk has joined the Max Perutz Labs as group leader in March 2019. He is interested in the mechanisms of gene silencing and the regulation…

Read more

Fighting genomic parasites – lessons from an unusual organism

Transposable elements (TEs) are parasitic DNA sequences that can jump within the host genome and disrupt its normal function. To preserve genome…

Read more

Valneva Announces Management Board Stock Purchases

Valneva SE (“Valneva” or “the Company”), a biotech company developing and commercializing vaccines for infectious diseases with major unmet needs,…

Read more

HOOKIPA Pharma Reports Second Quarter 2019 Financial Results and Clinical Progress Highlights

HOOKIPA Pharma Inc. reported recent clinical progress highlights and financial results for the second quarter ended June 30, 2019.

“In the second…

Read more

Profiling the stem-cell characters in the story of stomach lining renewal

Using an unbiased labelling technique, mathematical modelling, and single cell profiling to trace the footsteps of stem cells and their daughters,…

Read more

Ares Genetics Launches Service Laboratory for NGS-based Molecular Drug Resistance Testing

Curetis N.V. announced that its wholly-owned subsidiary Ares Genetics GmbH has opened a specialized service laboratory offering next-generation…

Read more